and trivalent vaccines. MMR vaccination was included in one of the large health maintenance organization case-control studies of possible serious bacterial infection after immunization (Black et al., 1991); although there was a trend toward fewer infections in vaccinees than in controls, none of the differences was significant.

At present, the data are insufficient to answer with certainty whether immunosuppression in the form of laboratory and skin test abnormalities after the receipt of a vaccine does, in fact, indicate a decrease in the capacity to resist infection. Therefore, as new vaccines are developed and as the old ones are used at different dosages or in different combinations or are administered at different ages, this question should continue to be a concern. To date, studies of current vaccines suggest that if immunization leads to an infection, it must do so infrequently.


Arthus M. Injections répétées de sérum de cheval chez le lapin. Comptes Rendus des Séances de la Société de Biologie et ses Filiales (Paris) 1903;55:817-820.

Benacerraf B, Kabat EA. A quantitative study of the Arthus phenomenon induced passively in the guinea pig. Journal of Immunology 1950;64:1-19.

Berkovich S, Fikrig S, Brunell PA, Portugalaza C, Steiner M. Effect of live attenuated mumps vaccine virus on the expression of tuberculin sensitivity. Journal of Pediatrics 1972;80:84-87.

Black SB, Cherry JD, Shinefield HR, Fireman B, Christenson P. Lampert D. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. American Journal of Diseases of Children 1991;145:746-749.

Brody JA, McAlister R. Depression of tuberculin sensitivity following measles vaccination. American Review of Respiratory Diseases 1964;90:611-617.

Brody JA, Overfield T, Hammes LM. Depression of the tuberculin reaction by vital vaccines. New England Journal of Medicine 1964;271:1294-1296.

Cohen P, Scadron SJ. Effects of active immunization of mother upon offspring. Journal of Pediatrics 1946;29:609-619.

Coombs RR, Gell PG. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PG, Coombs RR, eds. Clinical Aspects of Immunology, 2nd edition. Oxford: Blackwell: 1968.

Davidson M, Letson W, Ward JI, Ball A, Bulkow L, Christenson P, et al. DTP immunization and susceptibility to infectious diseases. American Journal of Diseases of Children 1991;145:750-754.

Dolovich J, Hargreave FE, Chalmeis R, Shier KJ, Cauldie J, Bienenstock J. Late cutaneous allergic responses in isolated-IgE-dependent reactions. Journal of Allergy and Clinical Immunology 1973;52:38-46.

Facktor MA, Bernstein RA, Fireman P. Hypersensitivity to tetanus toxoid. Journal of Allergy and Clinical Immunology 1973;52:1-12.

Fisher M. Anaphylaxis. Diseases of Man 1987;33:433-479.

Ganguly R, Cusumano CL, Waldman RH. Suppression of cell-mediated immunity after infection with attenuated rubella virus. Infection and Immunity 1976;13:464-469.

Goldblatt D, Turner MW, Levinsky RJ. Branhamella catarrhalis: antigenic determinants and

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement